Infographic
DLL3 Across Neuroendocrine Carcinomas: A Visual Guide
09/03/2026
This infographic provides a practical overview of delta-like ligand 3 (DLL3) across high-grade neuroendocrine carcinomas (NECs), highlighting its expression across NEC subtypes and emerging therapeutic relevance in extrapulmonary NEC (epNEC). The infographic highlights the role of DLL3 as a therapeutic rather than diagnostic biomarker, the importance of IHC-based assessment and evolving scoring thresholds, and pathologists’ central role in testing, tissue stewardship, and clinical trial readiness.
© 2026 HMP Global. All Rights Reserved.
